DeepMed: A unified, modular pipeline for end-to-end deep learning in computational pathology
van Treeck, M.; Cifci, D.; Ghaffari Laleh, N.; Saldanha, O. L.; Loeffler, C. M. L.; Hewitt, K. J.; Muti, H. S.; Echle, A.; Seibel, T.; Seraphin, T. P.; Trautwein, C.; Foersch, S.; Luedde, T.; Truhn, D.; Kather, J. N.
Show abstract
The interpretation of digitized histopathology images has been transformed thanks to artificial intelligence (AI). End-to-end AI algorithms can infer high-level features directly from raw image data, extending the capabilities of human experts. In particular, AI can predict tumor subtypes, genetic mutations and gene expression directly from hematoxylin and eosin (H&E) stained pathology slides. However, existing end-to-end AI workflows are poorly standardized and not easily adaptable to new tasks. Here, we introduce DeepMed, a Python library for predicting any high-level attribute directly from histopathological whole slide images alone, or from images coupled with additional meta-data (https://github.com/KatherLab/deepmed). Unlike earlier computational pipelines, DeepMed is highly developer-friendly: its structure is modular and separates preprocessing, training, deployment, statistics, and visualization in such a way that any one of these processes can be altered without affecting the others. Also, DeepMed scales easily from local use on laptop computers to multi-GPU clusters in cloud computing services and therefore can be used for teaching, prototyping and for large-scale applications. Finally, DeepMed is user-friendly and allows researchers to easily test multiple hypotheses in a single dataset (via cross-validation) or in multiple datasets (via external validation). Here, we demonstrate and document DeepMeds abilities to predict molecular alterations, histopathological subtypes and molecular features from routine histopathology images, using a large benchmark dataset which we release publicly. In summary, DeepMed is a fully integrated and broadly applicable end-to-end AI pipeline for the biomedical research community.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Exploring Integrative Analysis using the BioMedical Evidence Graph 94%
- Actionability of Synthetic Data in a Heterogeneous and Rare Healthcare Demographic; Adolescents and Young Adults (AYAs) with Cancer 93%
- DeepPhe-CR: Natural Language Processing Software Services for Cancer Registrar Case Abstraction 93%
Similar papers in this journal
- Aggregation of Cohorts for Histopathological Diagnosis with Deep Morphological Analysis 94%
- ARA: accurate, reliable and active histopathological image classification framework with Bayesian deep learning 94%
- Spatial Transcriptomics Inferred from Pathology Whole-Slide Images Links Tumor Heterogeneity to Survival in Breast and Lung Cancer 94%
Similar papers in this journal
- OCTAD: an open workplace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features 93%
- Inferring cellular and molecular processes in single-cell data with non-negative matrix factorization using Python, R, and GenePattern Notebook implementations of CoGAPS 93%
- CellChat for systematic analysis of cell-cell communication from single-cell and spatially resolved transcriptomics 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.